New EULAR recommendations on the use of DMARDs in the treatment of rheumatoid arthritis have included the use of JAK inhibitors for the first time. Member of the 50 strong international Task Force Associate Professor Peter Nash said the therapy was not yet available in Europe but the group realised they will be an option ...
Updated: EULAR recommendations for DMARDs in RA include JAK inhibitors
By Nicola Garrett
13 Mar 2017